Schroder Investment Management Group Dyne Therapeutics, Inc. Transaction History
Schroder Investment Management Group
- $94.5 Billion
- Q3 2024
A detailed history of Schroder Investment Management Group transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 90,041 shares of DYN stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,041
Previous 142,303
36.73%
Holding current value
$1.28 Million
Previous $5.02 Million
35.59%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
207Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$114 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$105 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$97.6 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$97 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$96.9 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $736M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...